Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 3.270
-0.080 (-2.39%)
Sep 10, 2026, 3:04 PM CST
SHE:300026 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,334 | 4,941 | 5,783 | 6,109 | 6,650 | 7,671 |
Revenue Growth | -22.35% | -14.55% | -5.34% | -8.14% | -13.30% | 18.22% |
Gross Profit Gross Profit Growth | 2,591 | 2,747 | 2,989 | 3,282 | 3,824 | 4,403 |
Operating Income Operating Income Growth | 219.38 | 177.81 | 102.42 | 515.52 | 724.42 | 1,002 |
Net Income Net Income Growth | 17.95 | 18.5 | 21.47 | 506.63 | 624.24 | 687.32 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | 0.01 | 0.17 | 0.21 | 0.23 |
EPS Growth | - | 0% | -94.12% | -19.05% | -8.70% | 21.05% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Chinese Medicine Formula Granules and Decoction Pieces Chinese Medicine Formula Granules and Decoction Pieces Growth | 2,461 | 2,669 | 2,923 | 3,360 |
Finished Medicine Finished Medicine Growth | 1,377 | 1,429 | 1,440 | 1,361 |
Excipients and APIs Excipients and APIs Growth | 428.24 | 481.51 | 512.61 | 544.75 |
Medical Instruments Medical Instruments Growth | 587.93 | 1,121 | 1,098 | 1,261 |
Others Others Growth | 87.2 | 81.88 | 134.72 | 123.24 |
Total Total Growth | 4,941 | 5,783 | 6,109 | 6,650 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,676 | 1,502 | 1,306 | 1,574 | 1,206 | 1,316 |
Total Debt Total Debt Growth | 386.24 | 531.1 | 852.07 | 1,533 | 2,091 | 1,965 |
Net Cash (Debt) Net Cash Growth | 1,289 | 971.06 | 454.12 | 40.24 | -884.45 | -648.87 |
Net Cash Growth | 96.19% | 113.83% | 1028.45% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.70 | 0.53 | 0.21 | 0.01 | -0.30 | -0.22 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 785.9 | 811.34 | 852.24 | 1,530 | 745.35 | 391.6 |
Capital Expenditures CapEx Growth | -103.72 | -130.25 | -193.12 | -347.12 | -770.27 | -677.45 |
Free Cash Flow Free Cash Flow Growth | 682.18 | 681.09 | 659.12 | 1,183 | -24.93 | -285.85 |
Free Cash Flow Growth | -1.67% | 3.33% | -44.28% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 59.78% | 55.59% | 51.69% | 53.73% | 57.50% | 57.40% |
Operating Margin | 5.06% | 3.60% | 1.77% | 8.44% | 10.89% | 13.07% |
Pretax Margin | 1.86% | 1.67% | 0.93% | 9.93% | 10.77% | 11.14% |
Profit Margin | 0.41% | 0.37% | 0.37% | 8.29% | 9.39% | 8.96% |
FCF Margin | 15.74% | 13.78% | 11.40% | 19.36% | -0.38% | -3.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.010 | 0.010 | 0.030 | 0.030 | 0.030 | 0.040 |
Dividend Per Share Growth | -66.67% | -66.67% | 0% | 0% | -25.00% | 0% |
Dividend Yield | 0.30% | 0.29% | 0.80% | 0.72% | 0.54% | 0.53% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 560.54 | 571.75 | 530.38 | 25.14 | 27.34 | 34.22 |
Forward PE | 23.93 | 21.33 | 20.21 | 15.40 | 25.24 | 16.83 |
P/FCF Ratio | 14.75 | 15.53 | 17.27 | 10.77 | - | - |
PS Ratio | 2.32 | 2.14 | 1.97 | 2.09 | 2.57 | 3.07 |